Colon - Tissue Tables
| Species | Species Detail | Cells | Enzyme(s) | Medium |
Reference |
| Human
|
Human |
Cancer stem cell |
Collagenase Type 3: 200 u/ml
Deoxyribonuclease I: 100 u/ml
|
RPMI-1640 |
Dalerba Piero, Dylla Scott J, Park In-Kyung, Liu Rui, Wang Xinhao, Cho Robert W, Hoey Timothy, Gurney Austin, Huang Emina H, Simeone Diane M, Shelton Andrew A, Parmiani Giorgio, Castelli Chiara, Clarke Michael F: Phenotypic characterization of human colorectal cancer stem cells, Proc. Natl. Acad. Sci. USA 104,
10158-63, 2007 |
| Human
|
Human |
colonic epithelial |
Collagenase:
Neutral Protease: 0.3%
Deoxyribonuclease I: 0.05%
|
RPMI 1640 |
Fukushima Kouhei, Fiocchi Claudio: Paradoxical decrease of mitochondrial DNA deletions in epithelial cells of active ulcerative colitis patients.,Am J Physiol Gastrointest Liver Physiol Vol. 286,,
,
G804-13, 2004 |
| Human
|
Human |
Colonic endothelial cells |
Collagenase Type 2: 0.25%
|
HBSS/5%FBS |
Wang D., Lehman R., Donner D., Matli M., Warren R., and Welton M.: Expression and Endocytosis of VEGF and Its Receptors in Human Colonic Vascular Endothelial Cells, Am. J. Physiol. / Gastro. 282,
G1088, 2002 |
| Human
|
Human |
Colonocytes |
Collagenase:
|
DMEM/F12 |
Emenaker N, Calaf G, Cox D, Basson M and Qureshi N: Short chain fatty acids differentially modulate cellular phenotype and c-myc protein levels in primary human nonmalignant and malignant colonocytes, J. Nutr. 46,
96-105, 2001 |
| Human
|
Human |
epithelial and mucosal lymphocytes |
Neutral Protease: 0.1%
CLSPA: 0.02%
Deoxyribonuclease I: 0.01%
|
RPMI 1640 |
Hisamatsu T, Watanabe M, Ogata H, Ezaki T, Hozawa S, Ishii H, Kanai T, Hibi T: Interferon-inducible gene family 1-8U expression in colitis-associated colon cancer and severely inflamed mucosa in ulcerative colitis., Cancer Res. 59,
5927-31, 1999 |
| Human
|
Human |
colonic epithelial |
Neutral Protease: 1.2 u/ml
Collagenase Type 4: 50 u/ml
|
HBSS |
Gibson PR, Rosella O, Wilson AJ, Mariadason JM, Rickard K, Byron K, Barkla DH: Colonic epithelial cell activation and the paradoxical effects of butyrate., Carcinogenesis
20,
539-44, 1999 |
| Human
|
Human |
Lamina propria lymphocytes |
Collagenase: 25 u/ml
|
HBSS |
Ueyama H, Kiyohara T, Sawada N, Isozaki K, Kitamura S, Kondo S, Miyagawa J, Kanayama S, Shinomura Y, Ishikawa H, Ohtani T, Nezu R, Nagata S, Matsuzawa Y: High Fas ligand expression on lymphocytes in lesions of ulcerative colitis, Gut 43,
48-55, 1998 |
| Mouse
|
Mouse, 6-8 week |
Cancer stem cell |
Collagenase Type 3: 200 u/ml
Deoxyribonuclease I: 100 u/ml
|
RPMI-1640 |
Dalerba Piero, Dylla Scott J, Park In-Kyung, Liu Rui, Wang Xinhao, Cho Robert W, Hoey Timothy, Gurney Austin, Huang Emina H, Simeone Diane M, Shelton Andrew A, Parmiani Giorgio, Castelli Chiara, Clarke Michael F: Phenotypic characterization of human colorectal cancer stem cells, Proc. Natl. Acad. Sci. USA 104,
10158-63, 2007 |
| Mouse
|
Mouse |
Lamina propria mononuclear cells |
Collagenase: 0.05%
Deoxyribonuclease I: 0.05%
Neutral Protease: 0.3%
|
HBSS |
Weigmann Benno, Tubbe Ingrid, Seidel Daniel, Nicolaev Alex, Becker Christoph, Neurath Markus F: Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue, Nat. Protoc.
2,
2307-11, 2007 |
| Mouse
|
Mouse |
dentritic |
Collagenase: 300 u/ml
Deoxyribonuclease I: .002%
|
RPMI 1640 |
Abe Kazumichi, Nguyen KimPhung, Fine SeanD, Mo Ji-Hun, Shen Carol, Shenouda Steve, Corr Maripat, Jung Steffen, Lee Jongdae, Eckmann Lars, Raz Eyal: Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells., Proc. Natl. Acad. Sci. USA 104,
17022-7, 2007 |
| Mouse
|
Mouse |
Lympocytes |
Collagenase/Dispase: 100 u/ml
|
RPMI 1640 |
Annacker O, Coombes JL, Malmstrom V, Uhlig HH, Bourne T, Johansson-Lindbom B, Agace WW, Parker CM, Powrie F.: Essential role for CD103 in the T cell-mediated regulation of experimental colitis, J. Exp. Med. 202,
1051, 2005 |
| Mouse
|
Mouse, 6-8 week |
Lamina propria lymphocytes |
Collagenase Type 1: 0.2%
Deoxyribonuclease I: 0.01%
|
HBSS |
Totsuka T, Kanai T, Uraushihara K, Iiyama R, Yamazaki M, Akiba H, Yagita H, Okumura K, Watanabe M: Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis, Am. J. Physiol. / Gastro. 284,
G595-603, 2003 |
| Mouse
|
Mouse, 6-8 week |
Lamina propria mononuclear cells |
Collagenase Type 2: 0.015%
Deoxyribonuclease I: 0.01%
|
RPMI |
Wirtz S., Becker C., Blumberg R., Galle P., and Neurath M.: Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA, J. Immunol. 168(1),
411, 2002 |
|
|